Yao, Y.; Findlay, A.; Stolp, J.; Rayner, B.; Ask, K.; Jarolimek, W.
Pan-Lysyl Oxidase Inhibitor PXS-5505 Ameliorates Multiple-Organ Fibrosis by Inhibiting Collagen Crosslinks in Rodent Models of Systemic Sclerosis. Int. J. Mol. Sci. 2022, 23, 5533.
https://doi.org/10.3390/ijms23105533
AMA Style
Yao Y, Findlay A, Stolp J, Rayner B, Ask K, Jarolimek W.
Pan-Lysyl Oxidase Inhibitor PXS-5505 Ameliorates Multiple-Organ Fibrosis by Inhibiting Collagen Crosslinks in Rodent Models of Systemic Sclerosis. International Journal of Molecular Sciences. 2022; 23(10):5533.
https://doi.org/10.3390/ijms23105533
Chicago/Turabian Style
Yao, Yimin, Alison Findlay, Jessica Stolp, Benjamin Rayner, Kjetil Ask, and Wolfgang Jarolimek.
2022. "Pan-Lysyl Oxidase Inhibitor PXS-5505 Ameliorates Multiple-Organ Fibrosis by Inhibiting Collagen Crosslinks in Rodent Models of Systemic Sclerosis" International Journal of Molecular Sciences 23, no. 10: 5533.
https://doi.org/10.3390/ijms23105533
APA Style
Yao, Y., Findlay, A., Stolp, J., Rayner, B., Ask, K., & Jarolimek, W.
(2022). Pan-Lysyl Oxidase Inhibitor PXS-5505 Ameliorates Multiple-Organ Fibrosis by Inhibiting Collagen Crosslinks in Rodent Models of Systemic Sclerosis. International Journal of Molecular Sciences, 23(10), 5533.
https://doi.org/10.3390/ijms23105533
